Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06372457 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Study acronym: COLLIGO-HCM
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary endpoints: details revised at 3 of 51 entries Completion pushed from Jun 30, 2026 to Dec 31, 2026 · Secondary endpoints: details revised at 4 of 18 entries · Publications: details revised at 1 of 1 entry · 1 more Show 4 more changesShow less
    • Completion pushed from Jun 30, 2026 to Dec 31, 2026
    • Secondary endpoints: details revised at 4 of 18 entries
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 3 words
  2. Primary completion date changed from estimate of Mar 1, 2025 to Sep 29, 2025 Enrollment target: estimated 500 to confirmed 331 · Completion date: Jun 15, 2025 to Jun 30, 2026v2 Show 2 more changesShow less
    • Enrollment target: estimated 500 to confirmed 331
    • Completion date: Jun 15, 2025 to Jun 30, 2026
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
COLLIGO-HCM is a global observational study that will conduct observational research of hypertrophic cardiomyopathy (HCM) treatment in real-world clinical practice.
Trial Details
NCT Number NCT06372457
Lead Sponsor Bristol-Myers Squibb
Conditions Hypertrophic Cardiomyopathy (HCM)
Enrollment 331 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov